Ludmila B. Bess, MD a Professional Corporation

Ludmila B. Bess, MD a Professional Corporation was paid $1.08M by Medicaid between Jan 2018 and Jul 2024, across 15 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 56% of everything it billed.

Compared with peers

Next to other Obstetrics & Gynecology Physician providers in California

Rank by total paid#115 of 791

Median peer was paid$67K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	210	$6K
2019	167	$5K
2020	7,169	$230K
2021	16,472	$415K
2022	16,620	$373K
2023	2,264	$47K
2024incomplete	616	$5K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	56%	12,245	6,420	$603K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	18%	12,904	6,635	$190K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	13%	8,413	4,530	$137K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	8,655	4,348	$123K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	1.2%	336	320	$13K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	292	177	$4K
99334		<1%	222	222	$3K
99326		<1%	72	72	$3K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	133	126	$3K
99335		<1%	65	65	$2K
76830	Ultrasound, transvaginal	<1%	107	106	$166.38
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	26	25	$31.19

3 more codes

Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	0%	18	$0.00
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	0%	18	$0.00
82272		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBESS, OLEG (PRESIDENT)